Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study

Background/aims The Dutch guidelines for diagnosis and treatment of upper-GI malignancies recommend review of patients by a multidisciplinary tumour board (MDT). The purpose of this study was to determine the effect on clinical decision making of an MDT for patients with upper-GI malignancies. Metho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical oncology 2013-04, Vol.18 (2), p.214-219
Hauptverfasser: van Hagen, Pieter, Spaander, Manon C. W., van der Gaast, Ate, van Rij, Caroline M., Tilanus, Hugo W., van Lanschot, J. Jan B., Wijnhoven, Bas P. L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 219
container_issue 2
container_start_page 214
container_title International journal of clinical oncology
container_volume 18
creator van Hagen, Pieter
Spaander, Manon C. W.
van der Gaast, Ate
van Rij, Caroline M.
Tilanus, Hugo W.
van Lanschot, J. Jan B.
Wijnhoven, Bas P. L.
description Background/aims The Dutch guidelines for diagnosis and treatment of upper-GI malignancies recommend review of patients by a multidisciplinary tumour board (MDT). The purpose of this study was to determine the effect on clinical decision making of an MDT for patients with upper-GI malignancies. Methods All physicians participating in the MDT completed an electronic standardised case form to delineate their proposed treatment plan for the patients they presented, including the intent of treatment and the modality of treatment. This therapeutic or diagnostic proposal was then compared with the plan on which consensus was reached by the MDT. Results A total of 252/280 (90.0%) forms were completed and suitable for analysis. In 87/252 (34.5%) of the case presentations, the MDT altered the proposed plan of management. In 29/87 (33.3%) cases, a more extensive diagnostic work-up was decided upon. In 8/87 (9.2%) cases the curative intent of the proposed treatment was altered to palliation only. In 2/75 (2.7%) cases, however, it was decided that a patient could be treated with curative intent instead of the proposed palliative intent. Conclusion In over 1/3 of cases, the diagnostic work-up or treatment plan is altered after evaluation by a multidisciplinary tumour board. This study supports Dutch guidelines recommending discussion of patients with upper-GI malignancies by a multidisciplinary tumour board.
doi_str_mv 10.1007/s10147-011-0362-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1326141561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1326141561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-f0144e3cc482ab8fa24c5ef10eb5e929e0c86749ec9e8c10cb1d7dc1f29b23c3</originalsourceid><addsrcrecordid>eNp1kU1rFTEUhoMoba39AW4k4Kab0Zwk8-VOim0vFNx0HzJnzlxTJ5MxyQjd-8PN5VYRoauE5Hnf8_Ey9hbEBxCi_ZhAgG4rAVAJ1ciqe8HOQKu2attWvix3paHqG1mfstcpPQgBbVPLE3YqJfSqUd0Z-7Xzq8XMw8Qt99uc3egSunV2i42PPG8-bJEPwcaRe6Lslj2fQuTbulKsbnbc29ntF7ugo8TDwrEoHdqZj4QuufLi7fei-lT81xjSSpjdT-IYvoWYecrb-PiGvZrsnOji6Txn99df7q9uq7uvN7urz3cValnnairTalKIupN26CYrNdY0gaChpl72JLBrWt0T9tQhCBxgbEeESfaDVKjO2eXRtvTxY6OUjS-z0jzbhcKWDCjZgIa6gYK-_w99KHtYSnMHqha6Bi0KBUcKy2Ap0mTW6HzZmwFhDgmZY0KmJGQOCZmuaN49OW-Dp_Gv4k8kBZBHIJWvZU_xn9LPuv4GqxmduQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1325045140</pqid></control><display><type>article</type><title>Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>van Hagen, Pieter ; Spaander, Manon C. W. ; van der Gaast, Ate ; van Rij, Caroline M. ; Tilanus, Hugo W. ; van Lanschot, J. Jan B. ; Wijnhoven, Bas P. L.</creator><creatorcontrib>van Hagen, Pieter ; Spaander, Manon C. W. ; van der Gaast, Ate ; van Rij, Caroline M. ; Tilanus, Hugo W. ; van Lanschot, J. Jan B. ; Wijnhoven, Bas P. L. ; Rotterdam Oesophageal Tumour Study Group</creatorcontrib><description>Background/aims The Dutch guidelines for diagnosis and treatment of upper-GI malignancies recommend review of patients by a multidisciplinary tumour board (MDT). The purpose of this study was to determine the effect on clinical decision making of an MDT for patients with upper-GI malignancies. Methods All physicians participating in the MDT completed an electronic standardised case form to delineate their proposed treatment plan for the patients they presented, including the intent of treatment and the modality of treatment. This therapeutic or diagnostic proposal was then compared with the plan on which consensus was reached by the MDT. Results A total of 252/280 (90.0%) forms were completed and suitable for analysis. In 87/252 (34.5%) of the case presentations, the MDT altered the proposed plan of management. In 29/87 (33.3%) cases, a more extensive diagnostic work-up was decided upon. In 8/87 (9.2%) cases the curative intent of the proposed treatment was altered to palliation only. In 2/75 (2.7%) cases, however, it was decided that a patient could be treated with curative intent instead of the proposed palliative intent. Conclusion In over 1/3 of cases, the diagnostic work-up or treatment plan is altered after evaluation by a multidisciplinary tumour board. This study supports Dutch guidelines recommending discussion of patients with upper-GI malignancies by a multidisciplinary tumour board.</description><identifier>ISSN: 1341-9625</identifier><identifier>EISSN: 1437-7772</identifier><identifier>DOI: 10.1007/s10147-011-0362-8</identifier><identifier>PMID: 22193638</identifier><language>eng</language><publisher>Japan: Springer Japan</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Cancer Research ; Decision Making ; Esophageal cancer ; Esophageal Neoplasms - diagnosis ; Esophageal Neoplasms - epidemiology ; Esophageal Neoplasms - pathology ; Esophageal Neoplasms - therapy ; Female ; Gastric cancer ; Gastroenterology ; Guidelines as Topic ; Humans ; Interdisciplinary Studies ; Male ; Medical diagnosis ; Medical treatment ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neoplasm Staging ; Netherlands - epidemiology ; Oncology ; Original Article ; Prospective Studies ; Surgical Oncology</subject><ispartof>International journal of clinical oncology, 2013-04, Vol.18 (2), p.214-219</ispartof><rights>Japan Society of Clinical Oncology 2011</rights><rights>Japan Society of Clinical Oncology 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-f0144e3cc482ab8fa24c5ef10eb5e929e0c86749ec9e8c10cb1d7dc1f29b23c3</citedby><cites>FETCH-LOGICAL-c425t-f0144e3cc482ab8fa24c5ef10eb5e929e0c86749ec9e8c10cb1d7dc1f29b23c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10147-011-0362-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10147-011-0362-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22193638$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Hagen, Pieter</creatorcontrib><creatorcontrib>Spaander, Manon C. W.</creatorcontrib><creatorcontrib>van der Gaast, Ate</creatorcontrib><creatorcontrib>van Rij, Caroline M.</creatorcontrib><creatorcontrib>Tilanus, Hugo W.</creatorcontrib><creatorcontrib>van Lanschot, J. Jan B.</creatorcontrib><creatorcontrib>Wijnhoven, Bas P. L.</creatorcontrib><creatorcontrib>Rotterdam Oesophageal Tumour Study Group</creatorcontrib><title>Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study</title><title>International journal of clinical oncology</title><addtitle>Int J Clin Oncol</addtitle><addtitle>Int J Clin Oncol</addtitle><description>Background/aims The Dutch guidelines for diagnosis and treatment of upper-GI malignancies recommend review of patients by a multidisciplinary tumour board (MDT). The purpose of this study was to determine the effect on clinical decision making of an MDT for patients with upper-GI malignancies. Methods All physicians participating in the MDT completed an electronic standardised case form to delineate their proposed treatment plan for the patients they presented, including the intent of treatment and the modality of treatment. This therapeutic or diagnostic proposal was then compared with the plan on which consensus was reached by the MDT. Results A total of 252/280 (90.0%) forms were completed and suitable for analysis. In 87/252 (34.5%) of the case presentations, the MDT altered the proposed plan of management. In 29/87 (33.3%) cases, a more extensive diagnostic work-up was decided upon. In 8/87 (9.2%) cases the curative intent of the proposed treatment was altered to palliation only. In 2/75 (2.7%) cases, however, it was decided that a patient could be treated with curative intent instead of the proposed palliative intent. Conclusion In over 1/3 of cases, the diagnostic work-up or treatment plan is altered after evaluation by a multidisciplinary tumour board. This study supports Dutch guidelines recommending discussion of patients with upper-GI malignancies by a multidisciplinary tumour board.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cancer Research</subject><subject>Decision Making</subject><subject>Esophageal cancer</subject><subject>Esophageal Neoplasms - diagnosis</subject><subject>Esophageal Neoplasms - epidemiology</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Neoplasms - therapy</subject><subject>Female</subject><subject>Gastric cancer</subject><subject>Gastroenterology</subject><subject>Guidelines as Topic</subject><subject>Humans</subject><subject>Interdisciplinary Studies</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medical treatment</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Netherlands - epidemiology</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Prospective Studies</subject><subject>Surgical Oncology</subject><issn>1341-9625</issn><issn>1437-7772</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kU1rFTEUhoMoba39AW4k4Kab0Zwk8-VOim0vFNx0HzJnzlxTJ5MxyQjd-8PN5VYRoauE5Hnf8_Ey9hbEBxCi_ZhAgG4rAVAJ1ciqe8HOQKu2attWvix3paHqG1mfstcpPQgBbVPLE3YqJfSqUd0Z-7Xzq8XMw8Qt99uc3egSunV2i42PPG8-bJEPwcaRe6Lslj2fQuTbulKsbnbc29ntF7ugo8TDwrEoHdqZj4QuufLi7fei-lT81xjSSpjdT-IYvoWYecrb-PiGvZrsnOji6Txn99df7q9uq7uvN7urz3cValnnairTalKIupN26CYrNdY0gaChpl72JLBrWt0T9tQhCBxgbEeESfaDVKjO2eXRtvTxY6OUjS-z0jzbhcKWDCjZgIa6gYK-_w99KHtYSnMHqha6Bi0KBUcKy2Ap0mTW6HzZmwFhDgmZY0KmJGQOCZmuaN49OW-Dp_Gv4k8kBZBHIJWvZU_xn9LPuv4GqxmduQ</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>van Hagen, Pieter</creator><creator>Spaander, Manon C. W.</creator><creator>van der Gaast, Ate</creator><creator>van Rij, Caroline M.</creator><creator>Tilanus, Hugo W.</creator><creator>van Lanschot, J. Jan B.</creator><creator>Wijnhoven, Bas P. L.</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study</title><author>van Hagen, Pieter ; Spaander, Manon C. W. ; van der Gaast, Ate ; van Rij, Caroline M. ; Tilanus, Hugo W. ; van Lanschot, J. Jan B. ; Wijnhoven, Bas P. L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-f0144e3cc482ab8fa24c5ef10eb5e929e0c86749ec9e8c10cb1d7dc1f29b23c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cancer Research</topic><topic>Decision Making</topic><topic>Esophageal cancer</topic><topic>Esophageal Neoplasms - diagnosis</topic><topic>Esophageal Neoplasms - epidemiology</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Neoplasms - therapy</topic><topic>Female</topic><topic>Gastric cancer</topic><topic>Gastroenterology</topic><topic>Guidelines as Topic</topic><topic>Humans</topic><topic>Interdisciplinary Studies</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medical treatment</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Netherlands - epidemiology</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Prospective Studies</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Hagen, Pieter</creatorcontrib><creatorcontrib>Spaander, Manon C. W.</creatorcontrib><creatorcontrib>van der Gaast, Ate</creatorcontrib><creatorcontrib>van Rij, Caroline M.</creatorcontrib><creatorcontrib>Tilanus, Hugo W.</creatorcontrib><creatorcontrib>van Lanschot, J. Jan B.</creatorcontrib><creatorcontrib>Wijnhoven, Bas P. L.</creatorcontrib><creatorcontrib>Rotterdam Oesophageal Tumour Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Hagen, Pieter</au><au>Spaander, Manon C. W.</au><au>van der Gaast, Ate</au><au>van Rij, Caroline M.</au><au>Tilanus, Hugo W.</au><au>van Lanschot, J. Jan B.</au><au>Wijnhoven, Bas P. L.</au><aucorp>Rotterdam Oesophageal Tumour Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study</atitle><jtitle>International journal of clinical oncology</jtitle><stitle>Int J Clin Oncol</stitle><addtitle>Int J Clin Oncol</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>18</volume><issue>2</issue><spage>214</spage><epage>219</epage><pages>214-219</pages><issn>1341-9625</issn><eissn>1437-7772</eissn><abstract>Background/aims The Dutch guidelines for diagnosis and treatment of upper-GI malignancies recommend review of patients by a multidisciplinary tumour board (MDT). The purpose of this study was to determine the effect on clinical decision making of an MDT for patients with upper-GI malignancies. Methods All physicians participating in the MDT completed an electronic standardised case form to delineate their proposed treatment plan for the patients they presented, including the intent of treatment and the modality of treatment. This therapeutic or diagnostic proposal was then compared with the plan on which consensus was reached by the MDT. Results A total of 252/280 (90.0%) forms were completed and suitable for analysis. In 87/252 (34.5%) of the case presentations, the MDT altered the proposed plan of management. In 29/87 (33.3%) cases, a more extensive diagnostic work-up was decided upon. In 8/87 (9.2%) cases the curative intent of the proposed treatment was altered to palliation only. In 2/75 (2.7%) cases, however, it was decided that a patient could be treated with curative intent instead of the proposed palliative intent. Conclusion In over 1/3 of cases, the diagnostic work-up or treatment plan is altered after evaluation by a multidisciplinary tumour board. This study supports Dutch guidelines recommending discussion of patients with upper-GI malignancies by a multidisciplinary tumour board.</abstract><cop>Japan</cop><pub>Springer Japan</pub><pmid>22193638</pmid><doi>10.1007/s10147-011-0362-8</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1341-9625
ispartof International journal of clinical oncology, 2013-04, Vol.18 (2), p.214-219
issn 1341-9625
1437-7772
language eng
recordid cdi_proquest_miscellaneous_1326141561
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Aged
Aged, 80 and over
Cancer Research
Decision Making
Esophageal cancer
Esophageal Neoplasms - diagnosis
Esophageal Neoplasms - epidemiology
Esophageal Neoplasms - pathology
Esophageal Neoplasms - therapy
Female
Gastric cancer
Gastroenterology
Guidelines as Topic
Humans
Interdisciplinary Studies
Male
Medical diagnosis
Medical treatment
Medicine
Medicine & Public Health
Middle Aged
Neoplasm Staging
Netherlands - epidemiology
Oncology
Original Article
Prospective Studies
Surgical Oncology
title Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T01%3A33%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20a%20multidisciplinary%20tumour%20board%20meeting%20for%20upper-GI%20malignancies%20on%20clinical%20decision%20making:%20a%20prospective%20cohort%20study&rft.jtitle=International%20journal%20of%20clinical%20oncology&rft.au=van%20Hagen,%20Pieter&rft.aucorp=Rotterdam%20Oesophageal%20Tumour%20Study%20Group&rft.date=2013-04-01&rft.volume=18&rft.issue=2&rft.spage=214&rft.epage=219&rft.pages=214-219&rft.issn=1341-9625&rft.eissn=1437-7772&rft_id=info:doi/10.1007/s10147-011-0362-8&rft_dat=%3Cproquest_cross%3E1326141561%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1325045140&rft_id=info:pmid/22193638&rfr_iscdi=true